Literature DB >> 1732726

Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.

S M Ruben1, R Narayanan, J F Klement, C H Chen, C A Rosen.   

Abstract

The NF-kappa B transcription factor complex is composed of two proteins, designated p50 and p65, both having considerable homology to the product of the rel oncogene. We present evidence that the p65 subunit is a potent transcriptional activator in the apparent absence of the p50 subunit, consistent with in vitro results demonstrating that p65 can interact with DNA on its own. To identify the minimal activation domain, chimeric fusion proteins between the DNA binding domain of the yeast transcriptional activator protein GAL4 and regions of the carboxy terminus of p65 were constructed, and their transcriptional activity was assessed by using a GAL4 upstream activation sequence-driven promoter-chloramphenicol acetyltransferase fusion. This analysis suggests that the boundaries of the activation domain lie between amino acids 415 and 550. Moreover, single amino acid changes within residues 435 to 459 greatly diminished activation. Similar to other activation domains, this region contains a leucine zipper-like motif as well as an overall net negative charge. To identify those residues essential for DNA binding, we made use of a naturally occurring derivative of p65, lacking residues 222 to 231 (hereafter referred to as p65 delta), and produced via an alternative splice site. Gel mobility shift analysis using bacterially expressed p65, p65 delta, and various mutants indicates that residues 222 to 231 are important for binding to kappa B DNA. Coimmunoprecipitation analysis suggests that these residues likely contribute to the multimerization function required for homomeric complex formation or heteromeric complex formation with p50 in that no association of p65 delta with itself or with p50 was evident. However, p65 delta was able to form weak heteromeric complexes with p65 that were greatly reduced in their ability to bind DNA. On the basis of these findings, we suggest that subtle changes within the proposed multimerization domain can elicit different effects with the individual Rel-related proteins and that a potential role of p65 delta may be to negatively regulate NF-kappa B function through formation of nonfunctional heteromeric complexes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732726      PMCID: PMC364189          DOI: 10.1128/mcb.12.2.444-454.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.

Authors:  S M Ruben; P J Dillon; R Schreck; T Henkel; C H Chen; M Maher; P A Baeuerle; C A Rosen
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

2.  Oncogenic transformation by vrel requires an amino-terminal activation domain.

Authors:  J Kamens; P Richardson; G Mosialos; R Brent; T Gilmore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

3.  vRel is an inactive member of the Rel family of transcriptional activating proteins.

Authors:  P M Richardson; T D Gilmore
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Transcription factors: a new family gathers at the cAMP response site.

Authors:  E B Ziff
Journal:  Trends Genet       Date:  1990-03       Impact factor: 11.639

5.  Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA.

Authors:  P J Dillon; P Nelbock; A Perkins; C A Rosen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.

Authors:  G P Nolan; S Ghosh; H C Liou; P Tempst; D Baltimore
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

7.  Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts.

Authors:  A J Capobianco; D L Simmons; T D Gilmore
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

8.  Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.

Authors:  S Ghosh; D Baltimore
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

9.  HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor.

Authors:  K Leung; G J Nabel
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

10.  NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit.

Authors:  M B Urban; R Schreck; P A Baeuerle
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  76 in total

1.  Inhibition of matrine against gastric cancer cell line MNK45 growth and its anti-tumor mechanism.

Authors:  Cong Luo; Hai Jun Zhong; Li Ming Zhu; Xian Guo Wu; Jie Er Ying; Xiao Hong Wang; Wang Xia Lü; Qi Xu; Yong Liang Zhu; Jian Huang
Journal:  Mol Biol Rep       Date:  2011-12-30       Impact factor: 2.316

2.  The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains.

Authors:  P J Morin; T D Gilmore
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

3.  Alternate RNA splicing of murine nfkb1 generates a nuclear isoform of the p50 precursor NF-kappa B1 that can function as a transactivator of NF-kappa B-regulated transcription.

Authors:  R J Grumont; J Fecondo; S Gerondakis
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

4.  Viral induction of the human beta interferon promoter: modulation of transcription by NF-kappa B/rel proteins and interferon regulatory factors.

Authors:  E Garoufalis; I Kwan; R Lin; A Mustafa; N Pepin; A Roulston; J Lacoste; J Hiscott
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

5.  Regulation of adhesion and growth of fibrosarcoma cells by NF-kappa B RelA involves transforming growth factor beta.

Authors:  J R Perez; K A Higgins-Sochaski; J Y Maltese; R Narayanan
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

6.  Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I kappa B gamma isoforms with different inhibitory activities.

Authors:  R J Grumont; S Gerondakis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model.

Authors:  R Narayanan; K A Higgins; J R Perez; T A Coleman; C A Rosen
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.

Authors:  A A Beg; T S Finco; P V Nantermet; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  Evidence for a non-alpha-helical DNA-binding motif in the Rel homology region.

Authors:  J Liu; M Sodeoka; W S Lane; G L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site.

Authors:  P A Oeth; G C Parry; C Kunsch; P Nantermet; C A Rosen; N Mackman
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.